文献速递瓣膜外科

透析依赖患者主动脉瓣或二尖瓣置换20年多中心分析:瓣膜选择启示

A 20-year multicenter analysis of dialysis-dependent patients who had aortic or mitral valve replacement: Implications for valve selection.
PubMed 文献 · J Thorac Cardiovasc Surg · 2018-12-13

仅30或40岁、无糖尿病且NYHA I-II级的患者估计5年生存率超过50%。

要点

  • 透析依赖患者瓣膜置换后长期生存差,5年生存率生物瓣23%、机械瓣33%。
  • 调整混杂因素后生物瓣与机械瓣长期生存无显著差异。
  • 仅年轻、无糖尿病且NYHA I-II级者可能从机械瓣获益,多数患者适合生物瓣。

核心结论

  • 透析依赖患者瓣膜置换术后长期生存率低,生物瓣与机械瓣调整后生存相似。
  • 年轻、无糖尿病且NYHA I-II级症状的患者可能生存足够长以考虑机械瓣,但生物瓣适合大多数患者。

研究设计与样本

  • 主要结局为长期生存,采用Cox回归模型按年龄、糖尿病和心力衰竭症状估计生存。

主要发现

  • 两组总体并发症发生率和30天死亡率相似。
  • 生物瓣组和机械瓣组5年生存率分别为23%和33%。

临床怎么用

  • 透析依赖患者瓣膜选择需个体化,多数患者适合生物瓣。
  • 对年轻、无糖尿病且NYHA I-II级的患者可考虑机械瓣,因其可能生存足够长。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Valve selection in dialysis-dependent patients can be difficult because long-term survival is diminished and bleeding risks during anticoagulation treatment are greater in patients with renal failure. In this study we analyzed long-term outcomes of dialysis-dependent patients who underwent valve replacement to help guide optimal prosthetic valve type selection. METHODS: Dialysis-dependent patients who underwent aortic and/or mitral valve replacement at 3 institutions over 20 years were examined. The primary outcome was long-term survival. A Cox regression model was used to estimate survival according to 5 ages, presence of diabetes, and/or heart failure symptoms. RESULTS: Four hundred twenty-three available patients were analyzed; 341 patients had biological and 82 had mechanical valves. Overall complication and 30-day mortality rates were similar between the groups. Thirty-day readmission rates for biological and mechanical groups were 15% (50/341) and 28% (23/82; P = .005). Five-year survival was 23% and 33% for the biological and mechanical groups, respectively. After adjusting for age, New York Heart Association (NYHA) class, and diabetes using a multivariable Cox regression model, survival was similar between groups (hazard ratio, 0.93; 95% confidence interval, 0.66-1.29; P = .8). A Cox regression model on the basis of age, diabetes, and heart failure, estimated that patients only 30 or 40 years old, with NYHA class I-II failure without diabetes had a >50% estimated 5-year survival (P < .001). CONCLUSIONS: Dialysis-dependent patients who underwent valve replacement surgery had poor long-term survival. Young patients without diabetes or NYHA III or IV symptoms might survive long enough to justify placement of a mechanical valve; however, a biological valve is suitable for most patients.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Manghelli JL, Carter DI, Khiabani AJ, et al. A 20-year multicenter analysis of dialysis-dependent patients who had aortic or mitral valve replacement: Implications for valve selection. J Thorac Cardiovasc Surg. 2018. PMID: 30685160. doi:10.1016/j.jtcvs.2018.10.168

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。